Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, during and after Vaccination

24Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The impact of coronavirus disease 2019 vaccination on viral characteristics of breakthrough infections is unknown. In this prospective cohort study, incidence of severe acute respiratory syndrome coronavirus 2 infection decreased following vaccination. Although asymptomatic positive tests were observed following vaccination, the higher cycle thresholds, repeat negative tests, and inability to culture virus raise questions about their clinical significance.

Cite

CITATION STYLE

APA

North, C. M., Barczak, A., Goldstein, R. H., Healy, B. C., Finkelstein, D. M., Ding, D. D., … Sacks, C. A. (2022). Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, during and after Vaccination. Clinical Infectious Diseases, 74(7), 1275–1278. https://doi.org/10.1093/cid/ciab643

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free